ICervsure

DNA Methylation Dection kit for Cervical Cancer

ICervsure is a non-invasive detection kit for in vitro qualitative detection of methylated SOX1 and PAX1 genes in cervical exfoliated cells of individuals who are tested positive for HPV, or diagnosed, through clinical cytology tests, with the results of ASC-US (atypical squamous cells of ambiguous significance), ASC-H (atypical cells of high-grade squamous intraepithelial lesions that could not be excluded), LSIL (low-grade squamous intraepithelial lesions) and HSIL (high-grade squamous intraepithelial lesions).

CE IVD ICervsure
ICervsure 1 ICervsure

Why ICervsure?

Cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020. About 90% of the new cases and deaths worldwide in 2020 occurred in low- and middle-income countries. Two human
papillomavirus (HPV) types (16 and 18) are responsible for nearly 50% of high grade cervical pre-cancers.

But HPV is not the only cause of cervical cancer. Most women with HPV don’t get cervical cancer, and other risk factors, like smoking, Chlamydia infection, Long-term use of oral contraceptives can increase chance of developing cervical cancer.

Cervical cancer is one of the most preventable and treatable forms of cancer, as long as it is detected early and managed effectively.

Staging of Cervical Cancer

c35 ICervsure

Why SOX1 and PAX1?

ICervsure Positive rates (95% CI)

 CIN1CIN2CIN3CANegative

ICervsure

Posivitive rate

33.33%

37.84%

68.47%

100.00%

91.19%

Abnormal DNA methylation is correlated with many human diseases including tumors.

In cervical cancer tissues, the cytosines in the CpG region of SOX1 and PAX1 genes are methylated, while the methylation rarely occurs in normal cervical tissues.

Researchers have found that the combined detection of SOX1 and PAX1 methylation can be used as an early indicator for cervical cancer screening.

Therefore, the above indicators are used as biomarkers of cervical cancer and precancerous lesions, and the detection of the methylation levels of SOX1 and PAX1 genes in cervical exfoliated cells can be used as ancillary diagnosis for cervical precancerous lesions and and early cervical cancer.

The Advantage of ICervsure

ICervsure 1 ICervsure

Accuracy

The sensitivity for detection of cancer is 100% and for precancerous lesions is 58.28%,The specificity is 90.3%.

ICervsure 3 ICervsure

Simple sampling

ICervsure can be performed on the same sample (self-sample or physician/ gynecologist collected) as the primary screening HPV test.

ICervsure 5 ICervsure

Easy operation

ICervsure can be performed on the mainstream brand qPCR machine.

ICervsure 2 ICervsure

Objective results

ICervsure provides objective results on whether a patient has a hrHPV infection that’s actively transforming cervical cells into cancer.

ICervsure 4 ICervsure

Save time & money

Avoid Unnecessary Colposcopy and Cervical Treatments.

ICervsure 6 ICervsure

Reduce anxiety

ICervsure provides test negative patients with peace of mind that they have a low short-term risk of cervical cancer.

Kit Components of ICervsure

n 9 ICervsure

Cell Direct Bisulfite Modification Kit

n 11 ICervsure

DNA Methylation Detection Kit for Cervical Cancer (Real-Time PCR)

c36 ICervsure

Testing Procedures

ICervsure 7 ICervsure

Sample collection

ICervsure
ICervsure 8 ICervsure

Pretreatment and extraction

ICervsure
ICervsure 9 ICervsure

Bisulfite conversion and purification

ICervsure
ICervsure 10 ICervsure

qPCR procedure

ICervsure
ICervsure 11 ICervsure

Analysis and Report

ICervsure 7 ICervsure

Sample collection

next 2 ICervsure
ICervsure 8 ICervsure

Pretreatment and extraction

next 2 ICervsure
ICervsure 9 ICervsure

Bisulfite conversion and purification

next 2 ICervsure
ICervsure 10 ICervsure

qPCR procedure

next 2 ICervsure
ICervsure 11 ICervsure

Analysis and Report

Result Interpretation

If the sample is tested positive, it means that the subject is at high risk of cervical precancerous lesions or early cervical cancer at the time of testing. A clinical diagnosis is recommended. If the sample is tested negative, it means that the subject is at low risk of cervical precancerous lesions or cancer at the time of testing. The subject is recommended to receive regular cervical cancer screening tests.

Gene methylation
Test results of samples
PAX1SOX1
PositivePositive
Positive
PositiveNegative
NegativePositive

Negative

Negative

Negative

Contact Us Right Now